All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti

 A who’s-who from the world of artificial organic analysis have come collectively to launch Senti Biosciences with $53 million in funding from a slew of enterprise capital buyers. Led by Tim Lu, a longtime researcher on the Massachusetts Institute of Know-how and one of many founding fathers of artificial biology, Senti’s purpose is nothing lower than growing therapies which are tailor-made… Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Adult Stem Cells – A Message of Hope – State of the Art Stem Cell Products

Splunk’s data analytics gets a security boost with $350 million acquisition of Phantom Cyber